News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BARBARI SHARON
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| BARBARI SHARON (Director) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 935 shares
@ $0
Granted 1,065 options to buy
@ $3.58, valued at
$3.8k
|
|
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| BARBARI SHARON (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Exercised 75,000 options
@ $1.48, valued at
$111k
|
|
| 08/05/2020 |
4
| BARBARI SHARON (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 22,500 options
@ $1.72, valued at
$38.7k
|
|
| 06/11/2020 |
4
| BARBARI SHARON (Director) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 26,786 shares
@ $0
Granted 45,212 options to buy
@ $2.8, valued at
$126.6k
|
|
| 03/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 29,271 options
@ $4.5, valued at
$131.7k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2019 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 49,412 options to buy
@ $2.66, valued at
$131.4k
|
|
| 03/02/2018 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 1,424 shares
@ $0 |
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2017 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 13,944 shares
@ $0 |
|
| 08/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2017 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 754 shares
@ $0 |
|
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2016 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Oculus Innovative Sciences, Inc.|
Txns:
| Granted 4,445 shares
@ $0 |
|
| 03/02/2016 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Oculus Innovative Sciences, Inc.|
Txns:
| Granted 4,356 shares
@ $0
Granted 11,250 shares
@ $0 |
|
| 02/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/02/2015 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Oculus Innovative Sciences, Inc.|
Txns:
| Granted 4,920 options to buy
@ $1.24, valued at
$6.1k
|
|
| 09/02/2015 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Oculus Innovative Sciences, Inc.|
Txns:
| Granted 5,109 options to buy
@ $1.21, valued at
$6.2k
|
|
| 06/02/2015 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Oculus Innovative Sciences, Inc.|
Txns:
| Granted 6,972 options to buy
@ $0.9, valued at
$6.3k
|
|
| 03/03/2015 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Oculus Innovative Sciences, Inc.|
Txns:
| Granted 7,246 options to buy
@ $0.86, valued at
$6.2k
|
|
| 03/02/2015 |
4
| BARBARI SHARON SURREY (EVP, Finance & CFO) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 12,151 options to buy
@ $7.96, valued at
$96.7k
Granted 62,849 options to buy
@ $7.96, valued at
$500.3k
|
|
| 12/02/2014 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Oculus Innovative Sciences, Inc.|
Txns:
| Granted 4,451 options to buy
@ $1.4, valued at
$6.2k
|
|
| 07/16/2014 |
4
| BARBARI SHARON SURREY (Director) has filed a Form 4 on Oculus Innovative Sciences, Inc.|
Txns:
| Granted 2,270 options to buy
@ $2.68, valued at
$6.1k
|
|
| 02/26/2014 |
4
| BARBARI SHARON SURREY (EVP, Finance & CFO) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 12,740 options to buy
@ $9.65, valued at
$122.9k
Granted 57,260 options to buy
@ $9.65, valued at
$552.6k
|
|
| 09/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2013 |
4
| BARBARI SHARON SURREY (EVP, Finance & CFO) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 134,728 options to buy
@ $1, valued at
$134.7k
Granted 165,272 options to buy
@ $1, valued at
$165.3k
|
|
| 09/05/2012 |
4
| BARBARI SHARON SURREY (EVP, Finance & CFO) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Paid exercise price by delivering 36,631 shares
@ $0.7598, valued at
$27.8k
Exercised 100,000 restricted stock units
@ $0 |
|
|
|
|